ABSTRACT To estimate the extent of myocardial infarction after coronary artery reperfusion, serum levels of cardiac myosin light chain (LC) I and creatine kinase (CK) were determined serially in 49 patients with acute myocardial infarction. Intracoronary thrombolysis was successful in 25 patients (reperfusion group), and 24 patients were treated in a conventional manner (control group). The peak level of CK appeared significantly earlier in the reperfusion group (1 1.3 + 3. 1 hr, mean + SD) than in the control group (21.6 ± 7.2 hr). Cumulative release of CK was significantly related to angiographically determined left ventricular ejection fraction 1 month after the attack in both groups (r = -.50; -.45, respectively). However, the amount of cumulative release of CK in the reperfusion group was greater compared with that in those with the same left ventricular ejection fraction in the control group. Peak appearance time of LCI was almost equal in the two groups (3.8 ± 1.4 vs 3.9 ± 1.2 days). Peak levels of LCI were related to the left ventricular ejection fraction in the reperfusion group (r = -.63) and in the control group (r = -.74), and the slopes of their regression lines were similar. The cardiac index obtained on the day of onset in the two groups was related to peak levels of LCI but not to total release of CK. These results suggest that serum levels of LCI reflect the changes in left ventricular function after acute myocardial infarction, regardless of the presence of coronary reperfusion. Thus, serial determinations of LCI in serum facilitate noninvasive assessment of the effects of intracoronary thrombolysis on infarct size. Circulation 76, No. 6, 1251-1261, 1987 IT HAS BEEN SHOWN that the intracoronary infusion of thrombolytic drugs can bring about coronary artery recanalization and this has been proposed as a way of reducing the extent of acute myocardial infarction. 1, 2 Although recent clinical investigations suggest beneficial effects of intracoronary thrombolysis,-5 many laboratory studies have pointed out the deleterious effects of coronary reperfusion, including massive myocardial hemorrhage, refractory arrhythmias, or noreflow phenomenon.68 Therefore, for evaluation of salvage and damage to the myocardium after throm-
IT HAS BEEN SHOWN that the intracoronary infusion of thrombolytic drugs can bring about coronary artery recanalization and this has been proposed as a way of reducing the extent of acute myocardial infarction. 1, 2 Although recent clinical investigations suggest beneficial effects of intracoronary thrombolysis,-5 many laboratory studies have pointed out the deleterious effects of coronary reperfusion, including massive myocardial hemorrhage, refractory arrhythmias, or noreflow phenomenon.68 Therefore, for evaluation of salvage and damage to the myocardium after throm-bolysis, the amount of necrotic myocardium should be estimated quantitatively without the influence of changes in coronary flow.
Several experimental9' 10 and clinical studies' [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] have shown that the early reflow of blood to ischemic myocardium increases the creatine kinase (CK) recovery rate. Accordingly, the total amount of CK that is released into the plasma may be greater than the amount of CK released from an area of myocardial necrosis of the same size without reperfusion. Previously, we have reported sensitive and specific radioimmunoassays for subunits of the cardiac myosin molecule, myosin light chain (LC) 1115, 16 and 1.17, 18 We have shown linear correlations between the levels of serum LCII and the extent of myocardial necrosis in experimental animals16, 19 20 
Methods
Study patients. Forty-nine of 102 consecutive patients with acute myocardial infarction were included in this study. Sixty of the 102 patients fulfilled the following criteria: (1) history of prolonged ischemic chest pain, (2) age less than 75 years, (3) no history or evidence of previous myocardial infarction, (4) time from onset of chest pain to hospital admission less than 10 hr, (5) electrocardiographic findings suggesting acute transmural myocardial infarction, as demonstrated by ST-T elevation in at least two leads, (6) availability of data from coronary cineangiography and left ventriculography performed during the chronic stage of infarction, and (7) blood samples for determination of CK withdrawn every 3 to 4 hr after the onset for at least 48 hr, and those for measurement of LCI withdrawn once or twice a day for at least 1 week. The diagnosis was confirmed in all patients by an increase in plasma CK. It was decided to undertake coronary angiography and left ventriculography irrespective of the results of CK and LCI measurements. Eleven of the 60 patients were excluded from the study because of recent history of trauma or surgical procedure, including intramuscular injection and use of an intra-aortic balloon pump.
Emergency coronary angiography and intracoronary infusion of urokinase were performed in 37 of the remaining 49 patients within 7 hr (4.1 + 0.4 hr, mean + SD) after the onset of symptoms. Of these 37 patients, 33 had total occlusion of the infarct-related artery, and the others had subtotal occlusion or severe stenosis of more than 90%. The reperfusion group (25 patients) included patients with antegrade coronary flow on angiography at the completion of urokinase infusion and sustained coronary flow on repeat angiography during the chronic stage. The control group (24 patients) included patients in whom coronary reperfusion was not present at the completion of urokinase infusion (12 patients) and patients in whom emergency coronary angiography was not performed (12 patients coronary artery disease, and the time interval between onset of infarction and angiographic examination during the chronic stage. There were more cases of anterior infarction in the reperfusion group than in the control group.
Acute catheterization protocol and subsequent therapy. Intracoronary thrombolysis was performed by the femoral artery approach. The occluded artery supplying the infarct area localized by electrocardiography was confirmed after intracoronary or sublingual administration of nitroglycerin or isosorbide dinitrate. Subsequently, 240,000 U of urokinase dissolved in either 5% dextrose or the patient's arterial blood was infused directly into the occluded artery over a period of 10 to 15 min. Arteriography was repeated after every dose. This procedure was discontinued when prompt antegrade flow was achieved or after 960,000 U of urokinase had been infused. Heart Association's recommendation.25 Each segment was scored as normal (n =3), hypokinetic (n =2), akinetic (n 1), or dyskinetic (n = 0). for the dilution of iodinated LCI, antisera, and standard antigen. The protein concentration of LCI for standards was determined by the method of Lowry. Radioimmunoassay was performed according to the following protocol. Reagents were added to 12 mm x 75 mm plastic tubes in the following order: (1) 200 ul of diluting buffer, (2) 100 p.l of a 1/2.5 dilution of sample to be assayed in duplicate or 100 ,ul of a serial dilution of standard LCI, ranging from 0.1 to 10 ng/100 ul in duplicate, (3) 100 ,u1 of antiserum, diluted 1:10,000 in phosphate-buffered saline containing 1% normal guinea pig serum to give a final dilution of 1 :10,000, and (4) 100 p.l of LC[1251] about 10,000 cpm. After incubation in the dark at 40 C for 2 days, 100 p.1 of anti-guinea pig gamma-globulin antiserum was added to each tube. After an additional 24 hr of incubation, the tubes were centrifuged at 40 C and 3000 rpm for 30 min. The supernatants were immediately aspirated and the precipitates were assayed for 1251.
Characteristics of radioimmunoassay. Figure 3 shows the displacement of LCI[12511 from anti-LCI antibody by increasing amounts of unlabeled pure LCI, LCII, and total LCs of human skeletal muscle. Amounts of 0.2 ng of LCI were effectively measurable. Cross-reactivity between LCI and total LCs of human skeletal muscle was calculated to be 10.2%. Serial dilutions of serum sample gave results indistinguishable from the standard curve. The intra-assay agreement was 4.8%. When 10 determinations from the same sample were made on different days over 5 months, the coefficient of variation was 9.5%. We also developed antisera to human LCII, but cross-reactivity between LCII and total LC of human skeletal muscle was much higher than that in the case of LCI. Normal range of serum LCI in 30 healthy volunteers was 3.7 + 0.9 ng/ml.
Blood samples for LCI assay were drawn every 12 hr for 48 hr after the onset of infarction and then at least once a day for 7 days or more. The peak level of LCI was also noted for each patient.
Chromatographic fractionation of the serum. The physical state of the immunoreactive product of human serum was analyzed to test the possibility that the prolonged elevation of LCI after acute myocardial infarction is due to the persistent circulation of LCI by itself or in a complex form.
Gel filtration experiments were performed with the use of a Sephadex-G 100 column (39.4cm X 1.0 cm) eluted with 10 mM potassium phosphate containing 0. 1M NaCl and 0.1% NaN3. Patient's serum (the concentration of LCI was 85 ng/ml) and purified cardiac myosin LCs (1 p.g/ml) were used for the chromatographic studies. Volumes of 0.5 ml of the serum or 0.2 ml Vol. 76, No. 6, December 1987 of the purified LCs were assayed by the radioimmunoassay method. The optical activity of the eluents of purified LCs at 280 nm was measured continuously using a ICHIBISHI SJ-1541 Spectrometer. The flow rate was 5.5 ml/hr and the fraction volume was 0.37 ml.
Statistical analysis. All data are expressed as the mean ± SD. Correlations were performed by linear regression analysis, computed by the least squares method. Comparisons among groups were carried out by unpaired Student's t test and the chi-squared test.
Results
CK kinetics. The configurations of the CK time-activity curves for the reperfusion group differed considerably from those for the control group. Plasma CK in the reperfusion group increased rapidly immediately after coronary reperfusion and reached a peak level much earlier than that in the control group. The time interval from the onset of symptoms to the peak level of CK in the reperfusion group (11.3 + 3. 1 hr) was earlier than that in the control group (21.6 + 7.2 hr; p< .001). This time interval was significantly related to the time interval from the onset of symptoms to confirmation of coronary reperfusion in the reperfusion group (r = .60, p<.01; figure 4). The correlation between peak CK and cumulative CK release was significant in each group (p<.001), and the ratio of peak CK to cumulative release of CK showed no statistical difference between the two groups. Time from onset to reperfusion (hours) symptoms and peak level of LCI in the reperfusion group and that in the control group were not statistically different (3.8 + 1.4 vs 3.9 ± 1.2 days, respectively).
Correlations between LCI levels and left ventricular function. Correlations between peak levels of LCI and both left ventricular ejection fraction ( figure 9 ) and left ventricular wall motion score (figure 10) were very good in the reperfusion group (r = -.63, p<.OO1 and r = -.54, p<.01, respectively) and in the control group (r = -.74, p<.OO1 and r = -.66, p<.OOl, respectively). Furthermore, the slope of the regression lines of the two groups were similar. Correlation coefficients for all patients were r = -.68 for left ventricular ejection fraction and r = -.59 for left ventricular wall motion score. The coefficient value for left ventricular ejection fraction vs peak LCI was significantly (p<.05) closer than that for left ventricular ejection fraction vs total CK release. As shown in table 2, all of the twenty-fourth-hour to fifth-day levels of LCI were correlated with left ventricular ejection fraction in both groups and the slopes of the regression lines were similar in both groups ( figure 11 ). Peak levels of LCI were also correlated with initial cardiac index obtained on the day of admission in all patients (r = -.51, p< .01) ( figure 12 ). However, the relationship between the cardiac index and peak LCI in the control group (r = -.85, p<.OO1) was much better than that in the reperfusion group. Chromatographic fractionation of the serum. The chromatographic profiles of the serum and the purified LCs are shown in the figure 13. The immunoreactive peak of the purified cardiac myosin LCs coincided with the peak ofthe optical activity and the first immunoreactive 1 2 3 4 5 6 7 8 9 10 1 1 12 peak of the serum sample corresponded to that of the purified LCs. The molecular weight (mol wt) of their first peak determined by the Gel Filtration Calibration Kit (Pharmacia) was approximately 29,000. Figure 13 shows the eluent immunoreactivity of both the serum and the purified cardiac myosin LCs. Sodium dodecyl sulfate polyacrylamide gel electrophoretic analysis of the purified total cardiac myosin LCs revealed two bands, which correspond to LCI (mol wt 27,000) and LCII (mol wt 20,000). The slight difference between the molecular weight of the immunoreactive peak ofthe eluents and the actual molecular weight of myosin LCI Left ventricular ejection fraction (%) FIGURE 9 . Correlation between left ventricular ejection fraction and peak levels of serum cardiac myosin LCI in patients treated conventionally (closed circles and solid line) and in patients with successful intracoronary thrombolysis (open circles and dotted line). The correlations were significant in each group and the slopes of the two regression lines were similar.
must be due to differences in methods because the immunoreactive peak ofthe purified total LCs appeared at a fraction very similar to that in the patient's serum.
Discussion
In the present study, we attempted to define the relationship between LCI release and angiographic estimates of infarct size for patients with successful intracoronary thrombolysis and those treated with conventional therapy. We found good correlations between serum LCI levels and left ventricular function after acute myocardial infarction in both patient groups with and without coronary reperfusion. In addition, the time and drugs. In addition, evaluation of patients with previous infarction is quite difficult. Therefore, for assessment of the extent of myocardial infarction after thrombolytic therapy and for evaluation of the clinical effects of coronary reperfusion, a biochemical index for estimation of infarct size is necessary. Our results are in general agreement with those of previous reports concerning CK release after coronary reperfusion.914 Vatner et al. 10 showed that CK release rate was accelerated and that the recovery rate of CK into the serum was increased in the presence of complete reperfusion in dogs. Tamaki et al. " also reported that the amount of CK-MB released into the plasma after successful intracoronary thrombolysis is greater than expected for an infarct size estimated from emission tomography with thallium-201 in man, because early reperfusion facilitates enzyme washout from the infarcted myocardium. Thus, prediction of infarct size from the time-activity curve of CK release for an individual patient after coronary reperfusion should be made with caution. However, the pattern of CK release could possibly be used as a noninvasive marker for early coronary reflow. 33 Washout of myocardial CK by effective reperfusion may affect the terminal portion of the time-activity curve of plasma CK. Since we believed that the errors introduced by the estimation of the disappearance rate of CK (Kd) from the downslope in an individual patient exceeded the advantages in this study, we used the mean Kd. 29 We also calculated CK release by the method of Norris et al.'3 but the results were similar.
We found that peak level and total release of LCII quantitatively reflect the extent of myocardial necrosis over a wide range of infarct sizes after experimental myocardial infarction. Although LCI is a component -E 00 Cardiac index ( /mn/m2) FIGURE 12 . Correlation between cardiac index and peak levels of cardiac myosin LCI. 
